SUMITOMO CHEMICAL INDIA LIMITED Financials Sumitomo Chemical India Limited Bombay S.E.
Equities
SUMICHEM
INE258G01013
Agricultural Chemicals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 499.3 INR | -0.34% |
|
+0.10% | +23.51% |
| May. 28 | Transcript : Sumitomo Chemical India Limited, Q4 2024 Earnings Call, May 28, 2024 | |
| May. 28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
Valuation
| Fiscal Period: Marzo | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 92,192 | 145,102 | 223,867 | 212,686 | 173,578 | 248,774 | - | - |
| Enterprise Value (EV) 1 | 91,039 | 139,991 | 219,891 | 212,686 | 173,578 | 248,774 | 248,774 | 248,774 |
| P/E ratio | 45 x | 42 x | 52.8 x | 42.4 x | 47 x | 50.8 x | 41.8 x | 32.2 x |
| Yield | 0.3% | 0.28% | 0.22% | 0.28% | 0.26% | 0.24% | 0.29% | 0.42% |
| Capitalization / Revenue | 3.8 x | 5.49 x | 7.3 x | 6.06 x | 6.1 x | 7.55 x | 6.4 x | 5.36 x |
| EV / Revenue | 3.8 x | 5.49 x | 7.3 x | 6.06 x | 6.1 x | 7.55 x | 6.4 x | 5.36 x |
| EV / EBITDA | 27.7 x | 29.8 x | 37.3 x | 31.9 x | 36.7 x | 40.3 x | 32.2 x | 26.1 x |
| EV / FCF | 50.3 x | 38 x | 207 x | 78.9 x | 27.6 x | 70.6 x | 54.9 x | - |
| FCF Yield | 1.99% | 2.63% | 0.48% | 1.27% | 3.62% | 1.42% | 1.82% | - |
| Price to Book | 7.55 x | 9.41 x | 11.6 x | 8.93 x | 7.1 x | 8.68 x | 7.3 x | 6.31 x |
| Nbr of stocks (in thousands) | 499,146 | 499,146 | 499,146 | 499,146 | 499,146 | 499,146 | - | - |
| Reference price 2 | 184.7 | 290.7 | 448.5 | 426.1 | 347.8 | 498.4 | 498.4 | 498.4 |
| Announcement Date | 6/5/20 | 5/28/21 | 5/27/22 | 5/18/23 | 5/27/24 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Marzo | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 24,247 | 26,449 | 30,646 | 35,110 | 28,439 | 32,957 | 38,845 | 46,433 |
| EBITDA 1 | 3,332 | 4,869 | 5,999 | 6,666 | 4,735 | 6,170 | 7,729 | 9,545 |
| EBIT 1 | 2,922 | 4,403 | 5,551 | 6,147 | 4,120 | 5,480 | 6,934 | 8,956 |
| Operating Margin | 12.05% | 16.65% | 18.11% | 17.51% | 14.49% | 16.63% | 17.85% | 19.29% |
| Earnings before Tax (EBT) 1 | 2,665 | 4,533 | 5,757 | 6,542 | 5,033 | 6,528 | 8,188 | 10,292 |
| Net income 1 | 2,047 | 3,454 | 4,236 | 5,022 | 3,697 | 4,925 | 6,177 | 7,651 |
| Net margin | 8.44% | 13.06% | 13.82% | 14.3% | 13% | 14.94% | 15.9% | 16.48% |
| EPS 2 | 4.100 | 6.920 | 8.490 | 10.06 | 7.400 | 9.813 | 11.93 | 15.47 |
| Free Cash Flow 1 | 1,834 | 3,822 | 1,083 | 2,695 | 6,283 | 3,524 | 4,534 | - |
| FCF margin | 7.56% | 14.45% | 3.53% | 7.68% | 22.09% | 10.69% | 11.67% | - |
| FCF Conversion (EBITDA) | 55.04% | 78.49% | 18.05% | 40.43% | 132.69% | 57.12% | 58.66% | - |
| FCF Conversion (Net income) | 89.6% | 110.64% | 25.56% | 53.66% | 169.92% | 71.56% | 73.4% | - |
| Dividend per Share 2 | 0.5500 | 0.8000 | 1.000 | 1.200 | 0.9000 | 1.200 | 1.450 | 2.100 |
| Announcement Date | 6/5/20 | 5/28/21 | 5/27/22 | 5/18/23 | 5/27/24 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: Marzo | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 7,072 | 6,651 | 9,855 | 11,217 | 7,537 | 6,516 | 7,242 | 9,035 | 5,420 | 6,742 | 8,230 |
| EBITDA 1 | 1,265 | 1,089 | 1,876 | 2,780 | 1,204 | 805.7 | 806.3 | 1,879 | 658.2 | 1,387 | 1,554 |
| EBIT 1 | - | - | - | - | - | - | - | - | 497 | 1,226 | 1,384 |
| Operating Margin | - | - | - | - | - | - | - | - | 9.17% | 18.18% | 16.82% |
| Earnings before Tax (EBT) | - | 1,041 | 1,797 | 2,720 | 1,209 | 816.2 | 833 | 1,955 | 753.5 | 1,487 | - |
| Net income 1 | - | 746.6 | 1,381 | 2,015 | 904.8 | 721.3 | 616.8 | 1,434 | 547.1 | 1,099 | 1,116 |
| Net margin | - | 11.23% | 14.02% | 17.96% | 12.01% | 11.07% | 8.52% | 15.88% | 10.09% | 16.3% | 13.57% |
| EPS 2 | - | - | - | - | - | - | - | - | 1.100 | 2.200 | 2.500 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/3/22 | 5/27/22 | 8/9/22 | 10/28/22 | 2/3/23 | 5/18/23 | 7/31/23 | 10/27/23 | 2/1/24 | 5/27/24 | - |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: Marzo | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | 1,153 | 5,110 | 3,976 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 1,834 | 3,822 | 1,083 | 2,695 | 6,283 | 3,524 | 4,534 | - |
| ROE (net income / shareholders' equity) | 18% | 25% | 24.4% | 23.3% | 15.3% | 18.2% | 19.3% | 20% |
| ROA (Net income/ Total Assets) | 10.3% | 14.5% | 14.9% | - | - | - | - | - |
| Assets 1 | 19,831 | 23,881 | 28,408 | - | - | - | - | - |
| Book Value Per Share 2 | 24.50 | 30.90 | 38.60 | 47.70 | 49.00 | 57.40 | 68.20 | 79.00 |
| Cash Flow per Share | - | 8.520 | - | - | - | - | - | - |
| Capex 1 | 380 | 433 | 1,135 | 1,199 | 1,315 | 1,625 | 1,938 | 2,250 |
| Capex / Sales | 1.57% | 1.64% | 3.7% | 3.41% | 4.62% | 4.93% | 4.99% | 4.85% |
| Announcement Date | 6/5/20 | 5/28/21 | 5/27/22 | 5/18/23 | 5/27/24 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
498.4
INR
Average target price
486.2
INR
Spread / Average Target
-2.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.11% | 36.87B | |
| -.--% | 11.62B | |
| +38.17% | 8.39B | |
| -6.04% | 7.25B | |
| +10.45% | 7.02B | |
| -10.89% | 5.71B | |
| -11.20% | 5.38B | |
| +35.90% | 5.31B | |
| -5.22% | 5.07B |
- Stock Market
- Equities
- SUMICHEM Stock
- SUMICHEM Stock
- Financials Sumitomo Chemical India Limited
